ATE510214T1 - Krankheitsdiagnose - Google Patents
KrankheitsdiagnoseInfo
- Publication number
- ATE510214T1 ATE510214T1 AT01998835T AT01998835T ATE510214T1 AT E510214 T1 ATE510214 T1 AT E510214T1 AT 01998835 T AT01998835 T AT 01998835T AT 01998835 T AT01998835 T AT 01998835T AT E510214 T1 ATE510214 T1 AT E510214T1
- Authority
- AT
- Austria
- Prior art keywords
- disease diagnosis
- disease
- protease
- diagnosis
- adhesion
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 230000017455 cell-cell adhesion Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 210000002919 epithelial cell Anatomy 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
- G01N2800/205—Scaling palpular diseases, e.g. psoriasis, pytiriasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0029225A GB0029225D0 (en) | 2000-11-30 | 2000-11-30 | Skin disease diagnosis and treatment |
| GB0029879A GB0029879D0 (en) | 2000-12-07 | 2000-12-07 | Skin disease diagnosis and treatment |
| PCT/GB2001/005303 WO2002044736A2 (en) | 2000-11-30 | 2001-11-30 | Diagnosis and treatment of epidermal or skin diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE510214T1 true ATE510214T1 (de) | 2011-06-15 |
Family
ID=26245355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01998835T ATE510214T1 (de) | 2000-11-30 | 2001-11-30 | Krankheitsdiagnose |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20040106120A1 (de) |
| EP (2) | EP1356298B1 (de) |
| JP (1) | JP2004524010A (de) |
| KR (1) | KR20030067696A (de) |
| AT (1) | ATE510214T1 (de) |
| AU (1) | AU2085502A (de) |
| CA (1) | CA2430473A1 (de) |
| WO (1) | WO2002044736A2 (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7374886B2 (en) | 1999-04-09 | 2008-05-20 | Rigshospitalet | Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer |
| NZ515311A (en) | 1999-04-09 | 2002-11-26 | Rigshospitalet | Mass screening and highly specific early identification of colorectal or metastatic breast cancer by measuring TIMP-1 tissue inhibitor |
| EP1247861A4 (de) * | 1999-12-06 | 2004-11-10 | Hidetoshi Inoko | Verfahren zur untersuchung der gemeinen psoriasis |
| US7019194B2 (en) | 2001-02-09 | 2006-03-28 | Lennart Hansson | SCCE modified transgenic mammals and their use as models of human disease |
| WO2002062135A2 (en) * | 2001-02-09 | 2002-08-15 | Egelrud Torbjoern | Scce modified transgenic mammals and their use as models of human disease |
| CA2522184A1 (en) * | 2003-04-17 | 2004-11-04 | The Trustees Of Columbia University In The City Of New York | Desmoglein 4 is a novel gene involved in hair growth |
| EP1716248A1 (de) * | 2004-02-03 | 2006-11-02 | Bayer HealthCare AG | Diagnostika und therapeutika für mit kallikrein 7 (klk7) assoziierten krankheiten |
| KR101286833B1 (ko) * | 2005-03-18 | 2013-07-17 | 가부시키가이샤 시세이도 | 편평상피세포암 관련 항원을 지표로 하는 피부 성상의 평가방법 |
| WO2006123955A2 (en) * | 2005-05-19 | 2006-11-23 | Synergenz Bioscience Limited | Methods for the assesssment of risk of developing lung cancer using analysis of genetic polymorphisms |
| WO2006123943A1 (en) * | 2005-05-20 | 2006-11-23 | Synergenz Bioscience Limited | Methods of analysis of polymorphisms and uses thereof |
| JP2009511572A (ja) * | 2005-10-16 | 2009-03-19 | イエダ リサーチ アンド ディベロップメント カンパニー リミテッド | 炎症性皮膚疾患、障害または症状のための医薬組成物および診断方法 |
| GB0604370D0 (en) * | 2006-03-03 | 2006-04-12 | Univ Dublin | Markers for melanoma progression |
| ES2375662T3 (es) * | 2006-03-17 | 2012-03-05 | Shiseido Company, Limited | Método para evaluar el nivel de sensibilidad de la piel mediante el uso del ant�?geno relacionado con el carcinoma de células escamosas como indicación. |
| CA2656022C (en) * | 2006-06-19 | 2017-10-17 | The Johns Hopkins University | Single-molecule pcr on microparticles in water-in-oil emulsions |
| JP4676448B2 (ja) * | 2007-01-22 | 2011-04-27 | 株式会社マルハニチロ水産 | タンパク質分解酵素阻害因子発現増強剤及びそれを含む皮膚の保水率改善剤 |
| WO2009045508A1 (en) * | 2007-10-02 | 2009-04-09 | Research Foundation Of City University Of New York | Novel protein transduction domains derived from secretory leukocyte protease inhibitor |
| JP2010115178A (ja) * | 2008-11-14 | 2010-05-27 | Nippon Menaade Keshohin Kk | 皮膚の炎症の予測方法及びその用途 |
| FR2940976B1 (fr) * | 2009-01-13 | 2017-11-03 | Oreal | Utilisation a des fins de criblage d'actifs anti-ages de formes solubles de la proteine de type desmogleine i |
| US20100318371A1 (en) * | 2009-06-11 | 2010-12-16 | Halliburton Energy Services, Inc. | Comprehensive hazard evaluation system and method for chemicals and products |
| ES2645416T3 (es) | 2009-11-23 | 2017-12-05 | Research Development Foundation | Polipéptidos de filagrina recombinantes para la importación a células |
| EP3046577A4 (de) * | 2013-09-20 | 2017-04-05 | Landegren, Nils | Neuartiges autoantigen |
| GB201509134D0 (en) * | 2015-05-28 | 2015-07-15 | Electrophoretics Ltd | Biomolecules involved in Alzheimer's disease |
| US20200040103A1 (en) | 2018-03-14 | 2020-02-06 | Genentech, Inc. | Anti-klk5 antibodies and methods of use |
| JP7140362B2 (ja) * | 2018-04-09 | 2022-09-21 | 国立大学法人東海国立大学機構 | 活性型組換えアクロシン |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| PH12022550646A1 (en) * | 2019-09-18 | 2023-04-03 | Genentech Inc | Anti-klk7 antibodies, anti-klk5 antibodies, multispecific anti-klk5/klk7 antibodies, and methods of use |
| WO2022192647A1 (en) * | 2021-03-12 | 2022-09-15 | Genentech, Inc. | Anti-klk7 antibodies, anti-klk5 antibodies, multispecific anti-klk5/klk7 antibodies, and methods of use |
| WO2025157595A2 (en) * | 2024-01-25 | 2025-07-31 | Lipotrue, S.L. | Peptides and cosmetic compositions for use in the treatment of acne and its related skin conditions |
| CN118440967B (zh) * | 2024-05-31 | 2025-02-07 | 内蒙古大学 | 一种具有抗菌活性的sprr2a原核表达系统及其构建方法和应用 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| DE3484332D1 (de) | 1983-02-10 | 1991-05-02 | Matsushita Electric Industrial Co Ltd | Porzellanzusammensetzung fuer spannungsabhaengigen nichtlinearen resistor. |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| NZ218336A (en) | 1985-12-09 | 1991-08-27 | Kirin Amgen Inc | Monoclonal antibodies to human pluripotent granulocyte colony stimulating factor (hpg-csf) |
| US5290762A (en) * | 1986-12-24 | 1994-03-01 | John Lezdey | Treatment of inflammation |
| US5190917A (en) * | 1986-12-24 | 1993-03-02 | John Lezdey | Treatment of psoriasis |
| CA1339351C (en) | 1987-10-15 | 1997-08-26 | Michael S. Urdea | Nucleic acid multimers and amplified nucleic acid hybridization assays using same |
| US5124246A (en) | 1987-10-15 | 1992-06-23 | Chiron Corporation | Nucleic acid multimers and amplified nucleic acid hybridization assays using same |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5091302A (en) | 1989-04-27 | 1992-02-25 | The Blood Center Of Southeastern Wisconsin, Inc. | Polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic applications thereof |
| US5552285A (en) | 1991-02-27 | 1996-09-03 | New York University | Immunoassay methods, compositions and kits for antibodies to oxidized DNA bases |
| AU2254792A (en) | 1991-07-01 | 1993-02-11 | Blood Center Of Southeastern Wisconsin, The | Pen polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic application thereof |
| FR2690691B1 (fr) | 1992-04-29 | 1999-02-12 | Bio Merieux | Procede d'amplification d'arn necessitant une seule etape de manipulation. |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| US5681699A (en) * | 1994-02-11 | 1997-10-28 | Cedars-Sinai Medical Center | Methods of diagnosing ulcerative colitis and Crohn's disease |
| US5922575A (en) | 1994-04-18 | 1999-07-13 | Mayo Foundation For Medical Education & Research | Mutations in the katG gene useful for detection of M. tuberculosis |
| US5633227A (en) * | 1994-09-12 | 1997-05-27 | Miles, Inc. | Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| US5654139A (en) | 1994-09-21 | 1997-08-05 | The United States Of America As Represented By The Department Of Health And Human Services | Allelic variation of the serotonin 5HT2c receptor |
| US5807678A (en) | 1995-03-23 | 1998-09-15 | Regents Of The University Of California | Identification of gene mutations associated with congenital lipoid adrenal hyperplasia |
| US5858661A (en) | 1995-05-16 | 1999-01-12 | Ramot-University Authority For Applied Research And Industrial Development | Ataxia-telangiectasia gene and its genomic organization |
| US5869242A (en) | 1995-09-18 | 1999-02-09 | Myriad Genetics, Inc. | Mass spectrometry to assess DNA sequence polymorphisms |
| JP2001510322A (ja) | 1996-03-29 | 2001-07-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | １８番染色体長腕（１８ｑ）上のマーカーに相関する両極性気分障害の治療法 |
| US5955266A (en) | 1996-04-01 | 1999-09-21 | The Johns Hopkins University School Of Medicine | Use of platelet polymorphism P1A2 to diagnose risk of thrombotic disease |
| US5691145A (en) | 1996-08-27 | 1997-11-25 | Becton, Dickinson And Company | Detection of nucleic acids using G-quartets |
| US5691153A (en) | 1996-09-06 | 1997-11-25 | Creighton University | Genetic markers to detect high bone mass |
| DE19813317A1 (de) | 1998-03-26 | 1999-09-30 | Roche Diagnostics Gmbh | Verbessertes Verfahren zur Primer Extension Präamplifikations-PCR |
| CA2312075A1 (en) * | 1998-11-05 | 2001-12-22 | Protease Sciences, Incorporated | Cosmetic compositions containing human type serine protease inhibitors |
| GB9906993D0 (en) * | 1999-03-26 | 1999-05-19 | Univ Leicester | Psoriasis |
| US6537968B1 (en) * | 2000-07-24 | 2003-03-25 | Alphamed Pharmaceuticals Corp | Treatment of lupus erythematosus |
-
2001
- 2001-11-30 US US10/433,234 patent/US20040106120A1/en not_active Abandoned
- 2001-11-30 WO PCT/GB2001/005303 patent/WO2002044736A2/en not_active Ceased
- 2001-11-30 KR KR10-2003-7007501A patent/KR20030067696A/ko not_active Ceased
- 2001-11-30 JP JP2002546227A patent/JP2004524010A/ja active Pending
- 2001-11-30 EP EP01998835A patent/EP1356298B1/de not_active Expired - Lifetime
- 2001-11-30 AU AU2085502A patent/AU2085502A/xx active Pending
- 2001-11-30 AT AT01998835T patent/ATE510214T1/de not_active IP Right Cessation
- 2001-11-30 EP EP10186268A patent/EP2357478A3/de not_active Withdrawn
- 2001-11-30 CA CA002430473A patent/CA2430473A1/en not_active Abandoned
-
2008
- 2008-01-17 US US12/016,012 patent/US20080292615A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2085502A (en) | 2002-06-11 |
| KR20030067696A (ko) | 2003-08-14 |
| US20080292615A1 (en) | 2008-11-27 |
| EP1356298A2 (de) | 2003-10-29 |
| US20040106120A1 (en) | 2004-06-03 |
| JP2004524010A (ja) | 2004-08-12 |
| CA2430473A1 (en) | 2002-06-06 |
| WO2002044736A3 (en) | 2003-08-28 |
| EP2357478A2 (de) | 2011-08-17 |
| EP2357478A3 (de) | 2011-11-16 |
| WO2002044736A2 (en) | 2002-06-06 |
| EP1356298B1 (de) | 2011-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE510214T1 (de) | Krankheitsdiagnose | |
| BRPI0516610A (pt) | enzimas | |
| DE69938600D1 (de) | Fusionsproteine und deren verwendung zur messung von protease-aktivität | |
| DK1694847T3 (da) | Serinproteaser, nucleinsyrer kodende for serinenzymer og vektorer og værtsceller omfattende disse. | |
| DE602005016892D1 (de) | Nukleinsäurecharakterisierung | |
| DE69939945D1 (de) | Verfahren zur isolierung von stammzellen | |
| DK1226271T3 (da) | DNA-sekventeringsmetode | |
| DK1131444T3 (da) | Polypeptider med lysophospholipase aktivitet og nucleinsyre som koder for disse | |
| ATE490466T1 (de) | Als interne funktionskontrolle in tests zum nachweis von seltenen zellen verwendete markierte zellen | |
| ATE456678T1 (de) | Nukleinsäurenachweisverfahren mit erhöhter empfindlichkeit | |
| EP1601779A4 (de) | Carbonsäurereduktase-polypeptid, dieses codierende nukleotidsequenz und verwendungsverfahren | |
| BR9912455A (pt) | ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória | |
| DK1495112T3 (da) | Cellekulturmedium | |
| ATE439441T1 (de) | Veränderte, fluoreszierende proteine | |
| MEP27908A (en) | Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium | |
| DE50107766D1 (de) | Zweifarbiges fluorimetrisches proteaseassay | |
| DK1248852T3 (da) | Fremgangsmåde til vurdering af levedygtigheden af en celle | |
| ATE538201T1 (de) | Kcnb: ein kaliumkanalprotein | |
| EP1141703A4 (de) | Verfahren zum bestimmen eines erhöhten risikos einer frau ein "down-syndrom" zu tragen | |
| ATE373723T1 (de) | Verbessertes verfahren zum nachweis von proteolytischen enzymen | |
| EP1512740A4 (de) | Von bacillus cereus produzierte cereulid-synthase, diese codierendes gen und verfahren zum nachweis von cereulid | |
| ATE403863T1 (de) | Verfahren zum nachweis von intrazellulären atp und/oder genexpression | |
| WO2001031009A3 (en) | Chandra: a th1-specific gene | |
| DE602006004966D1 (de) | Intrinsic-faktor vom schwein | |
| WO2005057486A3 (en) | Protein engineering with analogous contact environments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |